Pharmapalooza 2 — six firms rock for charity

Share this article:
Pharmapalooza 2 — six firms rock for charity
Pharmapalooza 2 — six firms rock for charity
Six healthcare agencies will plug in their amps and battle it out for musical supremacy — and for charity — when Pharmapalooza 2, the industry's band contest, takes over the legendary B.B. King Blues Club & Grill in New York City on Thursday, Nov. 5 at 8pm.

Organizer Cline Davis & Mann (CDM) will once again donate all proceeds to the Children's Hospital at Montefiore. The inaugural Pharmapalooza, held in 2007, raised more than $110,000 for the world-renowned pediatric hospital in the Bronx as a sold-out crowd of 750 industry colleagues and supporters roared on Heavy Medical (Corbett Accel Chicago) to victory.

This year's hot contenders include BandRx (AgencyRx), Late Night Car Service (Sudler & Hennessey), BöM (CDM), Male Nurse (GSW Worldwide), Pharma's Daughter (ghg) and No Indication (AbelsonTaylor).

Tickets will be available at the door on a first-come, first-serve basis, priced at $40 each (cash only). B.B. King Blues Club & Grill is located at 237 West 42nd Street in Manhattan. Doors open at 7pm and the show starts at 8pm.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...